摘要
背景:在血液,间质液,胃肠液,眼泪等体液中含有较多浓度的阳离子和阴离子。离子反应药物递送可用于设计独特的剂量制剂,其提供优化的药物治疗,有效,安全和方便地给予药物。 目标:本次审查的目的是收集,总结和分类关于离子响应给药系统的最新研究成果。 结果:体液/制剂中的离子引起制剂中所含聚合物/分子的结构变化,使制剂显示出功能。对离子响应的聚合物/分子是离子交换树脂/纤维,阴离子或阳离子聚合物,在较低临界溶液温度下表现出过渡的聚合物,自组装超分子体系,肽和金属有机骨架。离子响应药物递送系统的功能被分类为受控药物释放,位点特异性药物释放,原位凝胶化,在目标位点长期保留以及增强药物渗透。通过口服,眼用,透皮和鼻用途径给药制剂在最近的文献中显示出显着的优点。 结论:最近有多种给药途径报道了多种对离子有响应的给药系统。这些系统的改进和进步可以最大限度地发挥药物潜力,并为世界各地的患者做出贡献
关键词: 离子响应药物递送系统,离子交换络合物,较低临界溶解温度,受控药物释放,盐析效应,掩味,原位凝胶化,眼睛延长保留。
图形摘要
Current Drug Targets
Title:Ion-Responsive Drug Delivery Systems
Volume: 19 Issue: 3
关键词: 离子响应药物递送系统,离子交换络合物,较低临界溶解温度,受控药物释放,盐析效应,掩味,原位凝胶化,眼睛延长保留。
摘要: Background: Some kinds of cations and anions are contained in body fluids such as blood, interstitial fluid, gastrointestinal juice, and tears at relatively high concentration. Ionresponsive drug delivery is available to design the unique dosage formulations which provide optimized drug therapy with effective, safe and convenient dosing of drugs.
Objective: The objective of the present review was to collect, summarize, and categorize recent research findings on ion-responsive drug delivery systems.
Results: Ions in body fluid/formulations caused structural changes of polymers/molecules contained in the formulations, allow formulations exhibit functions. The polymers/molecules responding to ions were ion-exchange resins/fibers, anionic or cationic polymers, polymers exhibiting transition at lower critical solution temperature, self-assemble supramolecular systems, peptides, and metalorganic frameworks. The functions of ion-responsive drug delivery systems were categorized to controlled drug release, site-specific drug release, in situ gelation, prolonged retention at the target sites, and enhancement of drug permeation. Administration of the formulations via oral, ophthalmic, transdermal, and nasal routes has showed significant advantages in the recent literatures.
Conclusion: Many kinds of drug delivery systems responding to ions have been reported recently for several administration routes. Improvement and advancement of these systems can maximize drugs potential and contribute to patients in the world.
Export Options
About this article
Cite this article as:
Ion-Responsive Drug Delivery Systems, Current Drug Targets 2018; 19 (3) . https://dx.doi.org/10.2174/1389450117666160527142138
DOI https://dx.doi.org/10.2174/1389450117666160527142138 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial: The Importance of Case Reports and Case Series in Helping Diagnose Rare Diseases
Current Respiratory Medicine Reviews A Review on Medical Image Registration as an Optimization Problem
Current Medical Imaging Nuclear Magnetic Resonance Spectroscopy and Genetic Disorders
Current Medicinal Chemistry Cytochromes P450 in Brain: Function and Significance
Current Drug Metabolism Frontier Lipid-Based Carrier Systems for Drug Targeting: A Laconic Review on Niosomes
Pharmaceutical Nanotechnology Lipoxygenase: An Emerging Target for Stroke Therapy
CNS & Neurological Disorders - Drug Targets Biology of Cholesterol Lowering in Atherosclerotic Plaques
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design Introduction from Editor-in-Chief
Current Rheumatology Reviews Alternative Approaches to the Discovery and Development of Telomerase- Targeted Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Novel Therapeutic Strategies in Infection and Cancer Management
Current Aging Science The Treatment of Painful Diabetic Neuropathy
Current Diabetes Reviews Targeted Drug Delivery and Imaging Using Mobile Milli/Microrobots: A Promising Future Towards Theranostic Pharmaceutical Design
Current Pharmaceutical Design Farnesyltransferase Inhibitors: A Detailed Chemical View on an Elusive Biological Problem
Current Medicinal Chemistry Prevention of Neointimal Hyperplasia by Local Application of Lentiviral Vectors Encoding Pin1 shRNA in Pluronic F127
Current Gene Therapy Utilization of Ribozymes as Antiviral Agents
Letters in Drug Design & Discovery Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?
Current Cancer Drug Targets Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry